2016 Fiscal Year Final Research Report
Development of novel molecular diagnosis methods of lung cancer by proteomic signature
| Project/Area Number |
25640076
|
|---|
| Research Category |
Grant-in-Aid for Challenging Exploratory Research
|
| Allocation Type | Multi-year Fund |
|---|
| Research Field |
Tumor diagnostics
|
|---|
| Research Institution | Nagoya University |
|---|
Principal Investigator |
|
|---|
| Project Period (FY) |
2013-04-01 – 2017-03-31
|
| Keywords | 肺癌 / プロテオミクス / 分子診断 |
|---|
| Outline of Final Research Achievements |
We obtained protein expression profiles from both lung cancer and normal lung specimens. Based upon the information as well as clinical information, we conducted bioinformatic analyses. The resulting proteomic signature could accurately predict both disease-free and overall survival. Accordingly, we have discovered a proteomic signature that can distinguish NSCLC patients with a high risk from those with a favorable prognosis.
|
| Free Research Field |
分子腫瘍学
|
